Vertex Pharma (VRTX) – Insiders' Blog
-
Biotechs Continue to Underperform (IBB)
-
Biotech Losing Streak Continues (IBB)
-
Wall Street Looks to Soothe Biotech's Holiday Meltdown (GILD) (CELG) (AMGN)
-
UPDATE: Vertex Pharma (VRTX) Said to End Sales, Distribution of Hep C Drug
-
Vertex (VRTX) Pops Higher, Enters Two New HCV Treatment Collaborations
-
Vertex (VRTX) Slumps on VX-809 Data Presentation
-
Gilead (GILD) Issues Strong '7977 Update, Shares Move Higher
-
Goldman Sachs Starts Vertex (VRTX) at Buy, Sees 16% Upside
-
Vertex (VRTX), Pharmasset (VRUS) Viable Plays in Burgeoning Hep-C Market - Cramer
-
Vertex (VRTX) Sinks on Citi Downgrade
-
MRK Looking At Acquisitions to Boost Their Drug Business
Back to VRTX Stock Lookup